John F. Woolley

Medicines Discovery Catapult — United Kingdom

Medicine · Health Sciences

16h-index1.2kcitations41works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(10), interferon and immune responses(7), Multiple Myeloma Research and Treatments(4), Immune Cell Function and Interaction(4), Immune cells in cancer(4)

Publications41 total

Abstract 1486: Early biomarker dynamics are associated with treatment efficacy in a preclinical model of radiotherapy combined with a DNA damage response agent
Cancer Research·2025
Abstract A004: Radiotherapy sensitizes preclinical models to DNA damage response agents
Molecular Cancer Therapeutics·2024
Differential Regulation of the STING Pathway in Human Papillomavirus–Positive and -Negative Head and Neck Cancers
Cancer Research Communications·2023· 9 citedOpen Access
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
Molecular Therapy·2023· 48 citedOpen Access
Neuroblastoma: an ongoing cold front for cancer immunotherapy
Journal for ImmunoTherapy of Cancer·2023· 30 citedOpen Access
Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunity
2023· 2 citedOpen Access
Data from STINGing Viral Tumors: What We Know from Head and Neck Cancers
2023Open Access
Data from STINGing Viral Tumors: What We Know from Head and Neck Cancers
2023Open Access
Supplementary Figure 1 from STINGing Viral Tumors: What We Know from Head and Neck Cancers
2023Open Access
Supplementary Figure 1 from STINGing Viral Tumors: What We Know from Head and Neck Cancers
2023Open Access
A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML
Leukemia Research·2022
Development of a bispecific Antibody–Drug Conjugate targeting CD7 and CD33 to treat Acute Myeloid Leukaemia
2022Open Access
P408: NRAS MUTATIONS ARE INVOLVED IN ACUTE MYELOID LEUKAEMIA DRUG RESISTANCE
HemaSphere·2022Open Access
Worked to the bone: antibody-based conditioning as the future of transplant biology
Journal of Hematology & Oncology·2022· 29 citedOpen Access
Abstract P175: Investigating inositol polyphosphate-4-phosphatase, type II (INPP4B) signaling and role in acute myeloid leukemia
Molecular Cancer Therapeutics·2021
DNA Damage/Repair Management in Cancers
2021· 36 citedOpen Access
Recent Progress in Interferon Therapy for Myeloid Malignancies
Frontiers in Oncology·2021· 16 citedOpen Access
STINGing Viral Tumors: What We Know from Head and Neck Cancers
Cancer Research·2021· 9 citedOpen Access
INPP4B drives lysosome biogenesis to restrict leukemic stem cell differentiation and promote leukemogenesis
2021· 6 citedOpen Access
Old Dog, New Trick: Type I IFN–Based Treatment for Acute Myeloid Leukemia
Molecular Cancer Research·2021· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Lekh N. Dahal(12), Leonardo Salmena(9), Emma Saulters(8), Thomas G. Cotter(7), Irakli Dzneladze(7), Mark D. Minden(7), Terence M. Jones(6), Meong Hi Son(5), Shankar Varadarajan(5), Ruijuan He(4), Martino Gabra(4), Paul T. Kennedy(4), Ayesha Rashid(4), Joanna Stanicka(3), Mark Sharobim(3), Joseph R. Slupsky(3), Fiona Healy(3), Michael D. Jain(3), Jehad F. Alhmoud(2), Lavinia Bhatt(2)